A STUDY TO DEVELOP ADDITIONAL SAFETY AND CLINICAL EXPERIENCE WITH NATRECOR HBNP (NESIRITIDE) IN THE TREATMENT OF PATIENTS WITH WORSENING CONGESTIVE HEART FAILURE WHO REQUIRE INPATIENT INTRAVENOUS THERAPY WITH MEDICATIONS THAT INFLUENCE THE TONE AND CALIBER OF BLOOD VESSELS: